Feldman WB - Search Results

1

Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.

Raimond VC, Feldman WB, Rome BN, Kesselheim AS. Raimond VC, et al. Among authors: feldman wb. Milbank Q. 2021 Mar;99(1):240-272. doi: 10.1111/1468-0009.12507. Milbank Q. 2021. PMID: 33751664 Free PMC article.

2

Surrogate Endpoints and Drug Regulation: What Is Needed to Clarify the Evidence.

Hey SP, Feldman WB, Jung EH, D'Andrea E, Kesselheim AS. Hey SP, et al. Among authors: feldman wb. J Law Med Ethics. 2019 Sep;47(3):381-387. doi: 10.1177/1073110519876167. J Law Med Ethics. 2019. PMID: 31560631

3

Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined Formulary.

Feldman WB, Avorn J, Kesselheim AS. Feldman WB, et al. JAMA Intern Med. 2020 Mar 1;180(3):454-456. doi: 10.1001/jamainternmed.2019.5337. JAMA Intern Med. 2020. PMID: 31790541 Free PMC article.

4

Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary.

Feldman WB, Rome BN, Lehmann LS, Kesselheim AS. Feldman WB, et al. JAMA Intern Med. 2020 Apr 1;180(4):597-601. doi: 10.1001/jamainternmed.2019.7018. JAMA Intern Med. 2020. PMID: 32011624 Free PMC article.

5

Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study.

Liu M, MacKenna B, Feldman WB, Walker AJ, Avorn J, Kesselheim AS, Goldacre B. Liu M, et al. Among authors: feldman wb. J R Soc Med. 2020 Sep;113(9):350-359. doi: 10.1177/0141076820918238. J R Soc Med. 2020. PMID: 32910868 Free PMC article.

6

Trends in Medicare Part D Inhaler Spending: 2012-2018.

Feldman WB, Gagne JJ, Kesselheim AS. Feldman WB, et al. Ann Am Thorac Soc. 2021 Mar;18(3):548-550. doi: 10.1513/AnnalsATS.202008-1082RL. Ann Am Thorac Soc. 2021. PMID: 33207126 Free PMC article. No abstract available.

7

The Future of Drug-Pricing Transparency.

Feldman WB, Rome BN, Avorn J, Kesselheim AS. Feldman WB, et al. N Engl J Med. 2021 Feb 11;384(6):489-491. doi: 10.1056/NEJMp2033734. Epub 2021 Jan 13. N Engl J Med. 2021. PMID: 33440087 No abstract available.

8

A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs.

Sarpatwari A, Mitra-Majumdar M, Bykov K, Avorn J, Woloshin S, Toyserkani GA, LaCivita C, Manzo C, Zhou EH, Pinnow E, Dal Pan GJ, Gagne JJ, Huybrechts KF, Feldman WB, Chin K, Kesselheim AS. Sarpatwari A, et al. Among authors: feldman wb. Drug Saf. 2021 Jul;44(7):743-751. doi: 10.1007/s40264-021-01070-2. Epub 2021 Apr 27. Drug Saf. 2021. PMID: 33904111

9

Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs.

Rome BN, Feldman WB, Desai RJ, Kesselheim AS. Rome BN, et al. Among authors: feldman wb. JAMA Netw Open. 2021 May 3;4(5):e218816. doi: 10.1001/jamanetworkopen.2021.8816. JAMA Netw Open. 2021. PMID: 33944925 Free PMC article.

10

Empirical Assessment of U.S. Coronavirus Disease 2019 Crisis Standards of Care Guidelines.

Bharadwaj M, Jezmir JL, Kishore SP, Winkler M, Diephus B, Haider H, Crowley CP, Pinilla-Vera M, Varon J, Baron RM, Feldman WB, Kim EY. Bharadwaj M, et al. Among authors: feldman wb. Crit Care Explor. 2021 Jul 15;3(7):e0496. doi: 10.1097/CCE.0000000000000496. eCollection 2021 Jul. Crit Care Explor. 2021. PMID: 34286282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results